دورية أكاديمية
Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.
| العنوان: | Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data. |
|---|---|
| المؤلفون: | Delaney KE; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Ngobeni T; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa., Woods CK; University of British Columbia, Vancouver, British Columbia, Canada., Gordijn C; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Claassen M; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa., Parikh U; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Harrigan PR; University of British Columbia, Vancouver, British Columbia, Canada., van Zyl GU; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa. |
| المصدر: | Tropical medicine & international health : TM & IH [Trop Med Int Health] 2023 Mar; Vol. 28 (3), pp. 186-193. Date of Electronic Publication: 2023 Jan 13. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9610576 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-3156 (Electronic) Linking ISSN: 13602276 NLM ISO Abbreviation: Trop Med Int Health Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Oxford : Blackwell Scientific Publications Original Publication: Oxford, UK : Blackwell Science Ltd, c1996- |
| مواضيع طبية MeSH: | HIV Infections*/drug therapy , HIV-1*/genetics , Drug Resistance, Viral*/genetics , Nanopore Sequencing*/methods, Humans ; HIV Seropositivity/diagnosis ; HIV Seropositivity/therapy ; Mutation |
| مستخلص: | Objectives: Low-capital-layout sequencing options from Oxford Nanopore Technologies (ONT) could assist in expanding HIV drug resistance testing to resource-limited settings. HIV drug resistance mutations often occur as mixtures, but current ONT pipelines provide a consensus sequence only. Moreover, there is no integrated pipeline that provides a drug resistance report from an ONT sequence file without intervention from skilled bioinformaticists. We therefore investigated Nano-RECall, which provides seamless drug resistance interpretation while requiring low-read coverage ONT sequence data from affordable Flongle or MinION flow cells and which provides mutation mixtures similar to Sanger Sequencing. Methods: We compared Sanger sequencing to ONT sequencing of the same HIV-1 subtype C polymerase chain reaction (PCR) amplicons, respectively using RECall and the novel Nano-RECall bioinformatics pipelines. Amplicons were from separate assays: (a) Applied Biosystems HIV-1 Genotyping Kit (ThermoFisher) spanning protease (PR) to reverse transcriptase (RT) (PR-RT) (n = 46) and (b) homebrew integrase (IN) (n = 21). The agreement between Sanger sequences and ONT sequences was assessed at nucleotide level, and at codon level for Stanford HIV drug resistance database mutations at an optimal ONT read depth of 400 reads only. Results: The average sequence similarity between ONT and Sanger sequences was 99.3% (95% CI: 99.1%-99.4%) for PR-RT and 99.6% (95% CI: 99.4%-99.7%) for INT. Drug resistance mutations did not differ for 21 IN specimens; 8 mutations were detected by both ONT- and Sanger sequencing. For the 46 PR and RT specimens, 245 mutations were detected by either ONT or Sanger, of these 238 (97.1%) were detected by both. Conclusions: The Nano-RECall pipeline, freely available as a downloadable application on a Windows computer, provides Sanger-equivalent HIV drug resistance interpretation. This novel pipeline combined with a simple workflow and multiplexing samples on ONT flow-cells would contribute to making HIV drug resistance sequencing feasible for resource-limited settings. (© 2023 John Wiley & Sons Ltd.) |
| References: | J Clin Microbiol. 2013 Aug;51(8):2754-7. (PMID: 23761150) Biochem Med (Zagreb). 2012;22(3):276-82. (PMID: 23092060) PLoS One. 2011;6(5):e19461. (PMID: 21602929) EClinicalMedicine. 2019 Mar 18;9:26-34. (PMID: 31143879) Viruses. 2020 Jun 05;12(6):. (PMID: 32516949) Genome Biol. 2016 Nov 25;17(1):239. (PMID: 27887629) Clin Infect Dis. 2019 Jan 7;68(2):177-187. (PMID: 30052811) HLA. 2020 Aug;96(2):141-162. (PMID: 32274854) J Virol. 2015 Aug;89(16):8540-55. (PMID: 26041299) Nat Methods. 2011 Jan;8(1):61-5. (PMID: 21102452) AIDS. 2019 May 1;33(6):941-951. (PMID: 30946148) Genome Biol. 2019 Jun 24;20(1):129. (PMID: 31234903) Cells. 2021 Sep 28;10(10):. (PMID: 34685559) Retrovirology. 2016 Dec 20;13(1):87. (PMID: 27998286) Viruses. 2020 Aug 04;12(8):. (PMID: 32759675) J Clin Microbiol. 2012 Jun;50(6):1936-42. (PMID: 22403431) Clin Infect Dis. 2006 Jun 1;42(11):1608-18. (PMID: 16652319) Hum Immunol. 2021 Nov;82(11):801-811. (PMID: 33745759) |
| معلومات مُعتمدة: | U01 CA200441 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Keywords: HIV drug resistance sequencing; Oxford Nanopore Technology; bioinformatics pipeline; codon-aware alignment; homopolymer error; sanger sequencing |
| تواريخ الأحداث: | Date Created: 20230104 Date Completed: 20230324 Latest Revision: 20240302 |
| رمز التحديث: | 20240302 |
| مُعرف محوري في PubMed: | PMC10230441 |
| DOI: | 10.1111/tmi.13851 |
| PMID: | 36599816 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1365-3156 |
|---|---|
| DOI: | 10.1111/tmi.13851 |